Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 152

    1.

    Treatment of resistant hypertension.

    Czarina Acelajado M, Calhoun DA.

    Minerva Cardioangiol. 2009 Dec;57(6):787-812.PMID: 19942848 [PubMed - in process]Related articles

    2.

    Reduction of blood pressure in patients with treatment-resistant hypertension.

    Acelajado MC, Calhoun DA, Oparil S.

    Expert Opin Pharmacother. 2009 Dec;10(18):2959-71.PMID: 19925047 [PubMed - in process]Related articles

    3.

    Current options for the treatment of resistant hypertension.

    Ahmed MI, Pisoni R, Calhoun DA.

    Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1385-93.PMID: 19900021 [PubMed - in process]Related articles

    4.

    Characterization and treatment of resistant hypertension.

    Pisoni R, Ahmed MI, Calhoun DA.

    Curr Cardiol Rep. 2009 Nov;11(6):407-13.PMID: 19863864 [PubMed - in process]Related articles

    5.

    Logically rectangular finite volume methods with adaptive refinement on the sphere.

    Berger MJ, Calhoun DA, Helzel C, Leveque RJ.

    Philos Transact A Math Phys Eng Sci. 2009 Nov 28;367(1907):4483-96.PMID: 19840977 [PubMed - in process]Related articles

    6.

    A dual propagation contours technique for semi-automated assessment of systolic and diastolic cardiac function by CMR.

    Feng W, Nagaraj H, Gupta H, Lloyd SG, Aban I, Perry GJ, Calhoun DA, Dell'Italia LJ, Denney TS Jr.

    J Cardiovasc Magn Reson. 2009 Aug 13;11(1):30.PMID: 19674481 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial.

    Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia LJ, Calhoun DA.

    Hypertension. 2009 Sep;54(3):475-81. Epub 2009 Jul 20.PMID: 19620517 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Use of single-pill combination therapy in the evolving paradigm of hypertension management.

    Calhoun DA.

    Expert Opin Pharmacother. 2009 Aug;10(12):1869-74.PMID: 19496740 [PubMed - indexed for MEDLINE]Related articles

    9.

    Triple antihypertensive therapy with amlodipine, valsartan, and hydrochlorothiazide: a randomized clinical trial.

    Calhoun DA, Lacourcière Y, Chiang YT, Glazer RD.

    Hypertension. 2009 Jul;54(1):32-9. Epub 2009 May 26.PMID: 19470877 [PubMed - indexed for MEDLINE]Related articles

    10.

    Resistant hypertension: who and how to evaluate.

    Acelajado MC, Calhoun DA.

    Curr Opin Cardiol. 2009 Jul;24(4):340-4.PMID: 19395953 [PubMed - in process]Related articles

    11.

    Sleep apnea, aldosterone, and resistant hypertension.

    Pimenta E, Calhoun DA, Oparil S.

    Prog Cardiovasc Dis. 2009 Mar-Apr;51(5):371-80. Review.PMID: 19249443 [PubMed - indexed for MEDLINE]Related articles

    12.

    Aldosterone and metabolic dysfunction: an unresolved issue.

    Pimenta E, Calhoun DA.

    Hypertension. 2009 Apr;53(4):585-6. Epub 2009 Feb 16. No abstract available. PMID: 19221210 [PubMed - indexed for MEDLINE]Related articles

    13.

    Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study.

    Flack JM, Calhoun DA, Satlin L, Barbier M, Hilkert R, Brunel P.

    J Hum Hypertens. 2009 Jul;23(7):479-89. Epub 2009 Jan 29.PMID: 19190658 [PubMed - indexed for MEDLINE]Related articles

    14.

    Aldosterone and cardiovascular disease.

    Gaddam KK, Pimenta E, Husain S, Calhoun DA.

    Curr Probl Cardiol. 2009 Feb;34(2):51-84. Review.PMID: 19135616 [PubMed - indexed for MEDLINE]Related articles

    15.

    Resistant hypertension and hyperaldosteronism.

    Gonzaga CC, Calhoun DA.

    Curr Hypertens Rep. 2008 Dec;10(6):496-503. Review.PMID: 18959838 [PubMed - indexed for MEDLINE]Related articles

    16.

    2008 American Heart Association Statement on diagnosis, evaluation, and treatment of resistant hypertension: what should we remember in everyday practice?

    Gonzaga CC, Calhoun DA.

    Pol Arch Med Wewn. 2008 Jul-Aug;118(7-8):396-7. No abstract available. PMID: 18714732 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.

    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.

    Curr Med Res Opin. 2008 Aug;24(8):2303-11. Epub 2008 Jun 28.PMID: 18593517 [PubMed - indexed for MEDLINE]Related articles

    18.

    Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

    Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM; American Heart Association Professional Education Committee.

    Circulation. 2008 Jun 24;117(25):e510-26.PMID: 18574054 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion.

    Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, Pimenta E, Aban I, Oparil S, Calhoun DA.

    Arch Intern Med. 2008 Jun 9;168(11):1159-64.PMID: 18541823 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

    Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM.

    Hypertension. 2008 Jun;51(6):1403-19. Epub 2008 Apr 7.PMID: 18391085 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Resistant hypertension and aldosteronism.

    Pimenta E, Calhoun DA.

    Curr Hypertens Rep. 2007 Nov;9(5):353-9. Review.PMID: 18177580 [PubMed - indexed for MEDLINE]Related articles

    23.

    Relation of dietary salt and aldosterone to urinary protein excretion in subjects with resistant hypertension.

    Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Aban I, Oparil S, Calhoun DA.

    Hypertension. 2008 Feb;51(2):339-44. Epub 2007 Dec 17.PMID: 18086955 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Aldosterone excess and resistance to 24-h blood pressure control.

    Pimenta E, Gaddam KK, Pratt-Ubunama MN, Nishizaka MK, Cofield SS, Oparil S, Calhoun DA.

    J Hypertens. 2007 Oct;25(10):2131-7.PMID: 17885558 [PubMed - indexed for MEDLINE]Related articles

    25.

    Aldosteronism and hypertension.

    Calhoun DA.

    Clin J Am Soc Nephrol. 2006 Sep;1(5):1039-45. Epub 2006 Jul 12. Review.PMID: 17699324 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Is there an unrecognized epidemic of primary aldosteronism? Pro.

    Calhoun DA.

    Hypertension. 2007 Sep;50(3):447-53; discussion 447-53. Review. No abstract available. PMID: 17679651 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Mechanisms and treatment of resistant hypertension.

    Pimenta E, Calhoun DA, Oparil S.

    Arq Bras Cardiol. 2007 Jun;88(6):683-92. Review. English, Portuguese. No abstract available. PMID: 17664996 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.

    Epstein M, Calhoun DA.

    Curr Hypertens Rep. 2007 Apr;9(2):98-105. Review.PMID: 17442219 [PubMed - indexed for MEDLINE]Related articles

    29.

    Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

    Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA.

    Chest. 2007 Feb;131(2):453-9.PMID: 17296647 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension.

    Calhoun DA.

    J Clin Hypertens (Greenwich). 2007 Jan;9(1 Suppl 1):19-24. Review.PMID: 17215651 [PubMed - indexed for MEDLINE]Related articles

    31.

    Primary aldosteronism: diagnosis and treatment.

    Pimenta E, Calhoun DA.

    J Clin Hypertens (Greenwich). 2006 Dec;8(12):887-93. Review.PMID: 17170615 [PubMed - indexed for MEDLINE]Related articles

    32.

    Aldosterone and cardiovascular disease: smoke and fire.

    Calhoun DA.

    Circulation. 2006 Dec 12;114(24):2572-4. No abstract available. PMID: 17159070 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Authors' Reply: Recent Advances in Neonatal Pharmacotherapy (September).

    Calhoun DA, Bhatt-Mehta V.

    Ann Pharmacother. 2006 Aug 15. [Epub ahead of print] No abstract available. PMID: 16912254 [PubMed - as supplied by publisher]Related articles

    34.

    Aldosterone, dietary salt, and renal disease.

    Pimenta E, Calhoun DA.

    Hypertension. 2006 Aug;48(2):209-10. Epub 2006 Jun 26. No abstract available. PMID: 16801481 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.

    Gaddam KK, Pratt-Ubunama MN, Calhoun DA.

    Expert Rev Cardiovasc Ther. 2006 May;4(3):353-9. Review.PMID: 16716096 [PubMed - indexed for MEDLINE]Related articles

    36.

    Use of aldosterone antagonists in resistant hypertension.

    Calhoun DA.

    Prog Cardiovasc Dis. 2006 May-Jun;48(6):387-96. Review.PMID: 16714158 [PubMed - indexed for MEDLINE]Related articles

    37.

    Recent advances in neonatal pharmacotherapy.

    Calhoun DA, Murthy SN, Bryant BG, Luedtke SA, Bhatt-Mehta V.

    Ann Pharmacother. 2006 Apr;40(4):710-9. Epub 2006 Mar 28. Review.PMID: 16569801 [PubMed - indexed for MEDLINE]Related articles

    38.

    Resistant or difficult-to-treat hypertension.

    Calhoun DA.

    J Clin Hypertens (Greenwich). 2006 Mar;8(3):181-6. Review.PMID: 16522995 [PubMed - indexed for MEDLINE]Related articles

    39.

    Cardiovascular risk of systolic versus diastolic blood pressure in Western and non-Western countries.

    Nishizaka MK, Calhoun DA.

    J Hypertens. 2006 Mar;24(3):435-6. No abstract available. PMID: 16467642 [PubMed - indexed for MEDLINE]Related articles

    40.

    Primary aldosteronism: diagnostic and therapeutic considerations.

    Nishizaka MK, Calhoun DA.

    Curr Cardiol Rep. 2005 Nov;7(6):412-7. Review.PMID: 16256009 [PubMed - indexed for MEDLINE]Related articles

    41.

    The role of aldosterone antagonists in the management of resistant hypertension.

    Nishizaka MK, Calhoun DA.

    Curr Hypertens Rep. 2005 Oct;7(5):343-7. Review.PMID: 16157075 [PubMed - indexed for MEDLINE]Related articles

    42.

    Developmental expression of chemokine receptor genes in the human fetus.

    Lu W, Gersting JA, Maheshwari A, Christensen RD, Calhoun DA.

    Early Hum Dev. 2005 Jun;81(6):489-96. Epub 2005 Mar 19.PMID: 15935926 [PubMed - indexed for MEDLINE]Related articles

    43.

    Validity of plasma aldosterone-to-renin activity ratio in African American and white subjects with resistant hypertension.

    Nishizaka MK, Pratt-Ubunama M, Zaman MA, Cofield S, Calhoun DA.

    Am J Hypertens. 2005 Jun;18(6):805-12.PMID: 15925740 [PubMed - indexed for MEDLINE]Related articles

    44.

    Aldosterone antagonism: an emerging strategy for effective blood pressure lowering.

    Pratt-Ubunama MN, Nishizaka MK, Calhoun DA.

    Curr Hypertens Rep. 2005 Jun;7(3):186-92. Review.PMID: 15913492 [PubMed - indexed for MEDLINE]Related articles

    45.

    Enteral administration of a simulated amniotic fluid to very low birth weight neonates.

    Christensen RD, Havranek T, Gerstmann DR, Calhoun DA.

    J Perinatol. 2005 Jun;25(6):380-5.PMID: 15830001 [PubMed - indexed for MEDLINE]Related articles

    46.

    Neutrophil-specific chemokines are produced by astrocytic cells but not by neuronal cells.

    Lu W, Maheshwari A, Misiuta I, Fox SE, Chen N, Zigova T, Christensen RD, Calhoun DA.

    Brain Res Dev Brain Res. 2005 Mar 31;155(2):127-34.PMID: 15804401 [PubMed - indexed for MEDLINE]Related articles

    47.

    Circulating CXC-chemokine concentrations in a murine intestinal ischemia-reperfusion model.

    Maheshwari A, Christensen RD, Calhoun DA, Dimmitt RA, Lacson A.

    Fetal Pediatr Pathol. 2004 Mar-Jun;23(2-3):145-57.PMID: 15768860 [PubMed - indexed for MEDLINE]Related articles

    48.

    The effects and comparative differences of neutrophil specific chemokines on neutrophil chemotaxis of the neonate.

    Fox SE, Lu W, Maheshwari A, Christensen RD, Calhoun DA.

    Cytokine. 2005 Feb 7;29(3):135-40. Epub 2004 Dec 8.PMID: 15613281 [PubMed - indexed for MEDLINE]Related articles

    49.

    IL-8/CXC ligand 8 survives neonatal gastric digestion as a result of intrinsic aspartyl proteinase resistance.

    Maheshwari A, Lu W, Guida WC, Christensen RD, Calhoun DA.

    Pediatr Res. 2005 Mar;57(3):438-44. Epub 2004 Dec 7.PMID: 15585673 [PubMed - indexed for MEDLINE]Related articles

    50.

    Weight gain and hypertension: the chicken-egg question revisited.

    Calhoun DA, Grassi G.

    J Hypertens. 2004 Oct;22(10):1869-71. Review. No abstract available. PMID: 15361756 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...